Delivery Order SPE2DB20D3103-SPE2DB25FM1K6
Award Date
12/27/24
Potential Completion Date
12/30/24
Potential Value
$19K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with an award ID of SPE2DB20D3101|SPE2DB24FRWA0, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of STELARA 90 MG/ML SYRINGEML, a specialty medication, with a ceiling value of $171,716.16. This is a delivery order contract with a firm fixed price pricing type, and the ultimate completion date is September 25, 2024. The contract does not have a set-aside...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $19,812.37, is for the procurement of STELARA 90 MG/ML syringes and has a delivery order contract type with a firm fixed price. The contract has an ultimate completion date of March 4, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $23,756.71, is for the delivery of STELARA 90 MG/ML syringes. This is a delivery order contract with a firm fixed price pricing type and an ultimate completion date of December 26, 2023. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen...
This federal contract award, valued at $17,355.53, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of STELARA 90 MG/ML syringes, a specialty medication, with an ultimate completion date of December 5, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $80,684.49, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of STELARA 90 MG/ML SYRINGEML, a specialized pharmaceutical product. The contract has an ultimate completion date of November 7, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the delivery of STELARA 45 MG/0.5 ML syringes. The $18,032.17 firm-fixed-price delivery order has an ultimate completion date of August 30, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025, which serves as a primary vehicle for the...
This federal contract award, with ID SPE2DB22D3301|SPE2DB24FY5XT, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of STELARA 90 MG/ML SYRINGEML, a specialty medication, and has a ceiling value of $46,483.36. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and an ultimate completion date of May 2, 2024. This contract award is not...
This federal contract award, with ID SPE2DB20D3103|SPE2DB25FM4W5, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of STELARA 90 MG/ML SYRINGEML, a pharmaceutical product, with a ceiling value of $20,820.68 and a performance period ending on January 29, 2025. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $42,641.27, is a Delivery Order for the supply of STELARA 90 MG/ML SYRINGEML, a specialty medication. The contract has an ultimate completion date of July 16, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order (contract) awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of STELARA 90 MG/ML syringes. The award is not set-aside and has a ceiling value of $8,441.00. The contract has a firm fixed price structure and runs through September 10, 2024. AmerisourceBergen, through its Corporate Office division, has been awarded multiple federal contracts by the DLA and other agencies to provide a wide range...